CClinicalTrials.gg
CompletedNCT06977984Updated Apr 9, 2026

Group Integrative Breathwork for Chronic Pain

An interventional study of Integrative Breathwork Intervention in Chronic Pain, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by University of Florida · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of the proposed research is to iteratively develop, pilot test, and refine an integrative breathwork intervention that is suitable for group delivery to individuals with chronic pain. The intervention will be evaluated for feasibility, acceptability, and plausibility for clinically significant effects in people with chronic musculoskeletal pain.

Read the detailed description

Multiple single-arm iterations of a group breathwork intervention will be conducted to refine and optimize the intervention and protocol. Upon completion of each iteration, quantitative and qualitative data will be gathered to identify possible modifications before proceeding with the next iteration. After achieving a satisfactory intervention, we will conduct a pilot randomized controlled trial compared to a waitlist control group. This work will provide initial evidence on the feasibility, acceptability, and plausibility of clinically significant effects of this type of multicomponent breathwork intervention for adults with chronic low back pain.

02

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • Breathwork
  • Chronic Pain
  • Integrative Breathwork Intervention
  • Chronic Musculoskeletal Pain
  • Breathing Therapy
  • Intervention Development
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 35 is below the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

University of Florida is the lead sponsor of 1,254 studies on the registry; 201 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 136 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Men and women 18-70 years of age.
  2. Chronic musculoskeletal pain lasting for at least 3 months as a symptom of axial pain (e.g., back, neck) or limb pain (e.g., shoulder, knee, hip, wrist).
  3. Average pain intensity of ≥ 4/10 for the past month.
  4. Access to internet with a valid email address
  5. Able to lay down and stay relatively still for one hour.

Exclusion criteria

Exclusion Criteria:

  1. Any suspicion of a medical (orthopedic, rheumatic or neurological) disease, that can fully explain the current level of severity of pain.
  2. Chronic pain possibly due to specific conditions (e.g., cancer, infection).
  3. Ongoing legal action or disability claim related to chronic pain.
  4. Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy, history of seizures) or moderate or severe symptoms from a previous brain injury, including stroke and traumatic brain injury.
  5. Respiratory disorder (e.g., chronic obstructive pulmonary disease) or moderate to severe asthma within the past 12 months.
  6. Activity limiting heart disease including cardiovascular or peripheral arterial disease.
  7. Uncontrolled hypertension (i.e. SBP/DBP of > 160/95) or orthostatic hypotension (e.g., issues with fainting).
  8. Serious acute physical injuries or major surgery within the past 6 months.
  9. Serious psychiatric disorder (e.g., schizophrenia, panic disorder) or mental health issues requiring hospitalization within the past 12 months or currently on antipsychotic medications.
  10. History of hospitalization or treatment of substance use disorder within the past 12 months.
  11. Currently undergoing curative or palliative chemotherapy or radiation.
  12. Pregnant.
  13. Glaucoma or detached retina.
  14. Current participation or participation in the past 2 months of an interventional research study.
  15. Cognitive impairment or factors that would preclude comprehension of material and/or full participation in the study.
  16. Any significant comorbidities or other reasons that, in the opinion of the investigators, could interfere with the study or lead to deleterious effects for the participant.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Integrative Breathwork Intervention

    The breathwork intervention will be delivered in groups of 2-5 participants with chronic musculoskeletal pain. A conscious connected breathing technique will be engaged in for 45-60 minutes.

    Behavioral: Integrative Breathwork Intervention

Interventions

  • BehavioralIntegrative Breathwork Intervention

    The breathwork intervention involves a sustained conscious connected breathing pattern where there is no pause between inhale and exhale. During the breathing, a participant is guided to pay attention to the strongest sensation from moment-to-moment (e.g., mindfulness of somatic sensations) and relax unnecessary effort or tension. Participants lay supine throughout the 60 minute session. The session ends with spontaneous, relaxed breathing and an opportunity to briefly share one's experience.

06

What researchers measure

Primary outcomes

  1. Treatment Acceptability

    Treatment acceptability and satisfaction of the breathwork intervention will be measured using several face-valid items rated on a 10-point scale (1-10) where higher scores represent greater treatment acceptability and satisfaction.

    Time frame: Day 1

  2. Change in Pain Intensity and Interference

    The Pain, Enjoyment, and General Activities (PEG-3) scale will be used to assess pain intensity and pain interference over the past week on average.

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

Secondary outcomes

  1. Patient's Global Impressions of Change

    The Patient's Global Impression of Change single-item measure asks participants to describe any changes in activity limitations, symptoms, emotions, and overall quality of life, related to their pain since the beginning of the treatment. (Higher scores represent greater impressions of benefit from the intervention.)

    Time frame: 1-week follow-up, 1-month follow-up

  2. Change in Pain Catastrophizing

    Assessed using the 13-item Pain Catastrophizing Scale. (Scores range from 0-52; higher scores represent higher levels of pain catastrophizing).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  3. Acute Treatment Effects

    Assessed using face-valid items related to feelings and emotions immediately before and after the intervention session. Scores will be calculated by subtracting post-intervention to pre-intervention where higher scores represent greater acute subjective effects.

    Time frame: Day 1

  4. Change in Pain Self-Efficacy

    Assessed using the 10-item Pain Self-Efficacy Scale. (0-6; higher scores represent higher levels of pain self-efficacy).

    Time frame: Change from Baseline to 1-month follow-up

  5. Change in Sleep Disturbances

    Assessed using the PROMIS-Sleep Disturbance 8b scale. (1-5; higher scores represent higher levels of sleep disturbance).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  6. Change in Sleep Related Impairment

    Assessed using the PROMIS-Sleep Related Impairment 8a scale. (1-5; higher scores represent higher levels of sleep related impairment).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  7. Change in Fatigue

    Assessed using the PROMIS Fatigue-8a scale. (1-5; higher scores represent higher levels of fatigue over the past week).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  8. Change in Whole Person Health

    Assessed using the Whole Person Health Index. (1-5; lower scores represent better levels of self-assessed health ).

    Time frame: Change from Baseline to 1-month follow-up

  9. Change in Stress

    Assessed using the 4-item Perceived Stress Scale. (0-4; higher scores represent higher levels of subjective stress over the past month).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  10. Change in Anxiety

    Assessed using the Generalized Anxiety Disorder-2 Questionnaire. (0-3; higher scores represent higher levels of anxiety over the past 2 weeks).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  11. Change in Depression

    Assessed using the Patient Health Questionnaire-2.(0-3; higher scores represent higher levels of depression over the past 2 weeks).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  12. Change in Fear Avoidance Beliefs

    Assessed using the 5-item Fear-Avoidance Beliefs Questionnaire-physical activity subscale. (0-6; higher scores represent higher levels of physical activity-related fear-avoidance beliefs).

    Time frame: Change from Baseline to 1-week follow-up, 1-month follow-up

  13. Change in Interoception

    Assessed using the Multidimensional Assessment of Interoceptive Awareness-2. (0-5; higher scores represent higher levels of interoception).

    Time frame: Change from Baseline to 1-month follow-up

  14. Change in Multisensory Sensitivity

    Assessed using the Multisensory Amplification Scale will be used to assess symptoms of central nervous system hypersensitivity, or central sensitization. (1-5; higher scores represent higher levels of sensory sensitivity).

    Time frame: Change from Baseline to 1-month follow-up

  15. Psychological Insight

    Assessed using the Psychological Insight Questionnaire where higher scores represent greater levels of psychological insight arising from the breathwork intervention.

    Time frame: 1-month follow-up

07

Study locations

1 site
  • University of Florida Clinical Research Center
    Gainesville, Florida 32603, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06977984
Lead sponsor
University of Florida
Responsible party
Sponsor
First posted
May 18, 2025
Start date
Jun 18, 2025
Primary completion
Mar 18, 2026
Completion
Mar 31, 2026
Last update
Apr 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion